{
  "trials": [
    {
      "id": "NCT00000001",
      "drug": "Metformin",
      "indication": "Polycystic Ovary Syndrome (PCOS)",
      "phase": "Phase 3",
      "status": "Completed",
      "summary": "Metformin evaluated for insulin-sensitizing effects and menstrual regulation in women with PCOS.",
      "results": "Improved ovulatory frequency and insulin sensitivity compared to placebo.",
      "start_date": "2010-01-15",
      "end_date": "2014-06-30"
    },
    {
      "id": "NCT00000002",
      "drug": "Metformin",
      "indication": "Breast Cancer (adjunct therapy)",
      "phase": "Phase 2",
      "status": "Active, not recruiting",
      "summary": "Evaluating metformin as adjuvant therapy to reduce recurrence in early-stage breast cancer patients with metabolic syndrome.",
      "results": "Preliminary signals of improved metabolic biomarkers; efficacy outcomes pending.",
      "start_date": "2018-05-01",
      "end_date": null
    },
    {
      "id": "NCT00000003",
      "drug": "Metformin",
      "indication": "Colorectal Cancer Prevention",
      "phase": "Phase 2",
      "status": "Completed",
      "summary": "Low-dose metformin given to high-risk patients to evaluate adenoma recurrence.",
      "results": "Reduced adenoma count in a subset of patients with hyperinsulinemia.",
      "start_date": "2012-03-10",
      "end_date": "2016-11-20"
    }
  ]
}
